The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 8, 2006, Pages 3395-3399

  Ota, Takashi ^a   Aihara, Makoto ^a   Saeki, Tadashiro ^a   Narumiya, Shuh ^b   Araie, Makoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; DICLOFENAC; LATANOPROST; PROSTAGLANDIN DERIVATIVE; PROSTANOID EP1 RECEPTOR; PROSTANOID EP2 RECEPTOR; PROSTANOID EP3 RECEPTOR; PROSTANOID RECEPTOR; TRAVOPROST; UNOPROSTONE ISOPROPYL ESTER; ANTIHYPERTENSIVE AGENT; EYE DROPS; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTAGLANDIN F; PROSTANOID RECEPTOR EP1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURNAL ANIMAL; DRUG RECEPTOR BINDING; GLAUCOMA; INTRAOCULAR PRESSURE; LIGHT DARK CYCLE; MICRONEEDLE METHOD; MOUSE; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROTEIN DEFICIENCY; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; CIRCADIAN RHYTHM; DRUG EFFECT; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; DICLOFENAC; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; RECEPTORS, PROSTAGLANDIN E;

EID: 33748098396     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0100     Document Type: Article

References (47)

1. Perry CM, McGavin JK, Culy CR, Ibbotson T. Latanoprost: an update of its use in glaucoma and ocular hypertension. Drugs Aging. 2003;20:597-630.
2. Sihota R, Saxena R, Agarwal HC, Gulati V. Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma. Arch Ophthalmol. 2004;122:185-189.
3. Sihota R, Saxena R, Agarwal HC, Pandey RM, Gulati V. Peak pressures: crossover study of timolol and latanoprost. Eur J Ophthalmol. 2003;13:546-552.
4. Crowston JG, Lindsey JD, Aihara M, Weinreb RN. Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor. Invest Ophthalmol Vis Sci. 2004;45:3555-3559.
5. Ota T, Aihara M, Narumiya S, Araie M. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor- deficient mice. Invest Ophthalmol Vis Sci. 2005;46:4159-4163.
6. Kashiwagi K, Kanai N, Tsuchida T, et al. Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism. Exp Eye Res. 2002;74:41-49.
7. Yousufzai SY, Ye Z, Abdel-Latif AA. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res. 1996;63:305-310.
8. Kashiwagi K, Tsukahara S. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost. Br J Ophthalmol. 2003;87:297-301.
9. Kaplan-Messas A, Naveh N, Avni I, Marshall J. Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye. Eur J Ophthalmol. 2003;13:18-23.
10. Golubovic S, Radmanovic BZ. Effects of prostaglandin E2 and cholinergic drugs on intraocular pressure. Pharmacology. 1982;25:149-153.
11. Bito LZ, Srinivasan BD, Baroody RA, Schubert H. Noninvasive observations on eyes of cats after long-term maintenance of reduced intraocular pressure by topical application of prostaglandin E2. Invest Ophthalmol Vis Sci. 1983;24:376-380.
12. Kaji Y, Hiraki S, Hirata H. [The effects of calcium antagonists on prostaglandin E2 reaction in rabbit eyes.] Nippon Ganka Gakkai Zasshi. 1994;98:825-831.
13. Hirata H, Hiraki S, Kaji Y, Takeda N, Fukuo Y, Tachinami K. [The effects of transcorneal administration of prostaglandin E2 on rabbit eyes.] Nippon Ganka Gakkai Zasshi. 1994;98:927-934.
14. Janssen LJ, Tazzeo T. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther. 2002;301:1060-1066.
15. Clarke DL, Giembycz MA, Patel HJ, Belvisi MG. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype. Br J Pharmacol. 2004;141:600-609.
16. Elmhurst JL, Betti PA, Rangachari PK. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors. J Pharmacol Exp Ther. 1997;282:1198-1205.
17. Wang RF, Lee PY, Mittag TW, Podos SM, Serle JB, Becker B. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys. Arch Ophthalmol. 1998;116:1213-1216.
18. Wang RF, Podos SM, Serle JB, Mittag TW, Ventosa F, Becker B. Effect of latanoprost or 8-iso prostaglandin E2 alone and in combination on intraocular pressure in glaucomatous monkey eyes. Arch Ophthalmol. 2000;118:74-77.
19. Serle JB, Wang RF, Mittag TW, Shen F, Podos SM. Effect of pilocarpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E2 0.1% on intraocular pressure in laser-induced glaucomatous monkey eyes. J Glaucoma. 2001;10:215-219.
20. Gabelt BT, Seeman JL, Podos SM, Mittag TW, Kaufman PL. Aqueous humor dynamics in monkeys after topical 8-iso PGE(2). Invest Ophthalmol Vis Sci. 2004;45:892-899.
21. Bhattacherjee P, Williams BS, Paterson CA. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists. Invest Ophthalmol Vis Sci. 1999;40:3047-3053.
22. Woodward DF, Bogardus AM, Donello JE, et al. Molecular characterization and ocular hypotensive properties of the prostanoid EP2 receptor. J Ocul Pharmacol Ther. 1995;11:447-454.
23. Waterbury LD, Eglen RM, Faurot GF, Cooper GF. EP3, but not EP2, FP, or TP prostanoid-receptor stimulation may reduce intraocular pressure. Invest Ophthalmol Vis Sci. 1990;31:2560-2567.
24. Krauss AH, Wiederholt M, Sturm A, Woodward DF. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle. Exp Eye Res. 1997;64:447-453.
25. Lindsey JD, Kashiwagi K, Boyle D, Kashiwagi F, Firestein GS, Weinreb RN. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res. 1996;15:869-875.
26. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 1997;38:2214-2223.
27. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997;38:2772-2780.
28. Biswas S, Bhattacherjee P, Paterson CA. Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues: a comparative immunohistochemical study. Prostaglandins Leukot Essent Fatty Acids. 2004;71:277-288.
29. Hizaki H, Segi E, Sugimoto Y, et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc Natl Acad Sci USA. 1999;96:10501-10506.
30. Ushikubi F, Segi E, Sugimoto Y, et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature. 1998;395:281-284.
31. Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology. 1996;103:138-147.
32. Aihara M, Lindsey JD, Weinreb RN. Reduction of intraocular pressure in mouse eyes treated with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:146-150.
33. Ota T, Murata H, Sugimoto E, Aihara M, Araie M. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation. Invest Ophthalmol Vis Sci. 2005;46:2006-2011.
34. Aihara M, Lindsey JD, Weinreb RN. Twenty-four-hour pattern of mouse intraocular pressure. Exp Eye Res. 2003;77:681-686.
35. Jumblatt MM, Paterson CA. Prostaglandin E2 effects on corneal endothelial cyclic adenosine monophosphate synthesis and cell shape are mediated by a receptor of the EP2 subtype. Invest Ophthalmol Vis Sci. 1991;32:360-365.
36. Ocklind A, Lake S, Wentzel P, Nister M, Stjernschantz J. Localization of the prostaglandin F2 alpha receptor messenger RNA and protein in the cynomolgus monkey eye. Invest Ophthalmol Vis Sci. 1996;37:716-726.
37. Schlotzer-Schrehardt U, Zenkel M, Nusing RM. Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci. 2002;43:1475-1487.
38. Takamatsu M, Hotehama Y, Goh Y, Mishima HK. Localization of prostaglandin E receptor subtypes in the ciliary body of mouse eye. Exp Eye Res. 2000;70:623-628.
39. Zhao C, Fujimoto N, Shichi H. Immunocytochemical localization of prostaglandin E2 receptor subtypes in porcine ocular tissues. I. Uveal tissues. J Ocul Pharmacol Ther. 1995;11:421-435.
40. Kamphuis W, Schneemann A, van Beek LM, Smit AB, Hoyng PF, Koya E. Prostanoid receptor gene expression profile in human trabecular meshwork: a quantitative real-time PCR approach. Invest Ophthalmol Vis Sci. 2001;42:3209-3215.
41. Mukhopadhyay P, Bian L, Yin H, Bhattacherjee P, Paterson C. Localization of EP(1) and FP receptors in human ocular tissues by in situ hybridization. Invest Ophthalmol Vis Sci. 2001;42:424-428.
42. Mukhopadhyay P, Geoghegan TE, Patil RV, Bhattacherjee P, Paterson CA. Detection of EP2, EP4, and FP receptors in human ciliary epithelial and ciliary muscle cells. Biochem Pharmacol. 1997;53:1249-1255.
43. Segi E, Sugimoto Y, Yamasaki A, et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun. 1998;246:7-12.
44. Sharif NA, Kelly CR, Crider JY, Williams GW, Xu SX. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther. 2003;19:501-515.
45. Taniguchi T, Haque MS, Sugiyama K, Hori N, Kitazawa Y. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocul Pharmacol Ther. 1996;12:489-498.
46. Crowston JG, Lindsey JD, Morris CA, Wheeler L, Medeiros FA, Weinreb RN. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice. Invest Ophthalmol Vis Sci. 2005;46:4571-4577.
47. Costagliola C, Parmeggiani F, Antinozzi PP, Caccavale A, Cotticelli L, Sebastiani A. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients. Exp Eye Res. 2005;81:610-615.